Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Merit Medical Systems, Inc.NASDAQ: MMSI
Net Income · Q3 FY2026 · quarter ended Sep 2026
Net income growth accelerates
Q3 FY2026 net income of $42.31M rose 52.4% year over year, ahead of the +35.2% change in trailing-twelve-month net income. Sequentially, it rose 9.0% from the prior quarter. Over 3 fiscal years it compounded at +19.9% a year.
Context
- Net income amounted to 8.5% of revenue in FY2025, down 0.4 pp from a year earlier.
- Net income increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 9 analysts of $262.47M (+104.3%) for the fiscal year ending Dec 2026, a step up from the +6.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $42.31M+9.0% QoQ
- Last fiscal yearDec 2025
- $128.49M+6.8% YoY
- LTMSep 2026
- $160.12M+35.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +52.4% | +75.7% | +23.2 pp |
| 1 year | +6.8% | +104.3% | +97.5 pp |
| 3-year CAGR | +19.9% | +34.6% | +14.7 pp |
| 5-year CAGR | +21.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 128.49M USD
- Year-over-year change
- +6.8%
- 4-year CAGR
- +27.6%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 128.49M | +6.8% |
| FY2024 | 2024-12-31 | 120.36M | +27.5% |
| FY2023 | 2023-12-31 | 94.41M | +26.7% |
| FY2022 | 2022-12-31 | 74.52M | +53.8% |
| FY2021 | 2021-12-31 | 48.45M | — |
Net Income vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's LTM Sep 2026 net income of $160.12M is the 5th largest of the 10 companies compared; the peer median is $54.85M.
- Its year-over-year change of +35.2% is the 5th highest of 10, against a peer median of +34.6%.
- Net income amounts to 9.9% of revenue for MMSI, versus a peer median of 10.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.67B | +34.6% | +60.6% | 17.5% | |
| LTM Jun 2026 | $1.43B | +277.4% | +5.0% | 17.3% | |
| LTM Sep 2026 | $1.22B | -27.5% | -9.2% | 6.0% | |
| LTM Jun 2026 | $320.9M | -267.2% | -45.6% | 12.3% | |
| LTM Sep 2026 | $160.12M | +35.2% | +19.9% | 9.9% | |
| LTM Mar 2026 | $62.4M | +38.2% | +40.9% | 24.3% | |
| LTM Mar 2026 | $54.85M | -53.8% | — | 4.0% | |
| LTM Feb 2026 | $31.39M | -24.2% | +8.6% | 10.0% | |
| LTM Jun 2026 | $30.09M | +181.4% | — | 1.4% | |
| LTM Jun 2026 | $10.55M | +129.0% | -37.3% | 1.9% | |
| Peer median (excluding MMSI) | $54.85M | +34.6% | +5.0% | 10.0% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 48.45M | 74.52M | 94.41M | 120.36M | 128.49M |
| Depreciation & Amortization | 95.78M | 92.2M | 101.29M | 114.73M | 134.65M |
| Deferred Income Tax | (4.63M) | (14.92M) | (12.64M) | (14.87M) | 5.21M |
| Stock-Based Compensation | 16.09M | 18.04M | 21.33M | 28.47M | 43.46M |
| Change in Working Capital | (17.84M) | (71.4M) | (70.02M) | (36.95M) | (23.34M) |
| Accounts Receivables | (8.62M) | (15.12M) | (9.55M) | (21.7M) | (2.73M) |
| Inventory | (25.18M) | (47.93M) | (32.11M) | (2.29M) | (21.6M) |
| Accounts Payables | 6.05M | 12.66M | (7.3M) | (2.31M) | 1.01M |
| Other Working Capital | 9.91M | (21.01M) | (21.08M) | (10.64M) | (26K) |
| Other Non-Cash Items | 9.37M | 15.86M | 10.78M | 9.06M | 8.9M |
| Operating Cash Flow | 147.23M | 114.29M | 145.15M | 220.8M | 297.37M |
| Capital Expenditures | (27.94M) | (45.03M) | (36.7M) | (38.04M) | (84.84M) |
| Acquisitions (Net) | (7.17M) | (8.29M) | (137.85M) | (320.18M) | (144.77M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (2.05M) | (4.08M) | (799K) | (10.43M) | (17.78M) |
| Investing Cash Flow | (37.16M) | (57.4M) | (175.35M) | (368.65M) | (247.39M) |
| Debt Repayment | (108.5M) | (44.94M) | 619.58M | (99.06M) | 0 |
| Common Stock Issued | 21.31M | 20.07M | 15.58M | 40.91M | 28.21M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (11.24M) | (35.39M) | (75.9M) | (1.85M) | (12.21M) |
| Financing Cash Flow | (98.44M) | (60.26M) | 559.27M | (60.01M) | 16M |
| Effect of Forex Changes | (801K) | (3.83M) | (484K) | (2.52M) | 3.8M |
| Net Change in Cash | 10.83M | (7.19M) | 528.59M | (210.38M) | 69.78M |
| Free Cash Flow | 119.29M | 69.26M | 108.45M | 182.76M | 212.54M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.